169 related articles for article (PubMed ID: 37232900)
1. New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia.
Roškar Z; Dreisinger M; Tič P; Homšak E; Bevc S; Goropevšek A
Biosensors (Basel); 2023 May; 13(5):. PubMed ID: 37232900
[TBL] [Abstract][Full Text] [Related]
2. STAT5 phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity.
Goropevšek A; Gorenjak M; Gradišnik S; Dai K; Holc I; Hojs R; Krajnc I; Pahor A; Avčin T
J Leukoc Biol; 2017 Jun; 101(6):1405-1418. PubMed ID: 28254841
[TBL] [Abstract][Full Text] [Related]
3. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
4. Assessing IL-2-Induced STAT5 Phosphorylation in Fixed, Permeabilized Foxp3
Li C; Park JH
STAR Protoc; 2020 Dec; 1(3):100195. PubMed ID: 33377089
[TBL] [Abstract][Full Text] [Related]
5. [The percentage of regulatory T cells in peripheral blood of chronic lymphocytic leukemia patients and the correlations with clinical prognosis].
Xie P; Pang N; Guo X; Wang L; Zhao F; Wang X; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1307-11. PubMed ID: 24321076
[TBL] [Abstract][Full Text] [Related]
6. Decreased regulatory function of CD4
Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.
Gowda A; Ramanunni A; Cheney C; Rozewski D; Kindsvogel W; Lehman A; Jarjoura D; Caligiuri M; Byrd JC; Muthusamy N
MAbs; 2010; 2(1):35-41. PubMed ID: 20081380
[TBL] [Abstract][Full Text] [Related]
8. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
Wang R; Huang K
Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
[TBL] [Abstract][Full Text] [Related]
9. CXCL4 promoted the production of CD4
Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
[No Abstract] [Full Text] [Related]
10. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.
Piper KP; Karanth M; McLarnon A; Kalk E; Khan N; Murray J; Pratt G; Moss PA
Clin Exp Immunol; 2011 Nov; 166(2):154-63. PubMed ID: 21985361
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3.
Dasgupta A; Mahapatra M; Saxena R
Leuk Lymphoma; 2013 Apr; 54(4):778-89. PubMed ID: 22989355
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
[TBL] [Abstract][Full Text] [Related]
15. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
16. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.
Mayer E; Bannert C; Gruber S; Klunker S; Spittler A; Akdis CA; Szépfalusi Z; Eiwegger T
PLoS One; 2012; 7(1):e29355. PubMed ID: 22272233
[TBL] [Abstract][Full Text] [Related]
17. The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.
Levitsky J; Miller J; Leventhal J; Huang X; Flaa C; Wang E; Tambur A; Burt RK; Gallon L; Mathew JM
Transplantation; 2009 Dec; 88(11):1303-11. PubMed ID: 19996930
[TBL] [Abstract][Full Text] [Related]
18. Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.
Bhattacharya K; Chandra S; Mandal C
Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800
[TBL] [Abstract][Full Text] [Related]
19. [The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients].
Fu JL; Xu DP; Shi M; Zhang H; Jin L; Tang ZR; Wang FS
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):642-5. PubMed ID: 17074148
[TBL] [Abstract][Full Text] [Related]
20. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
